Being able to target multiple key cascades leading to AD pathogenesis, including Aβ aggregation, tau phosphorylation, oxidative stress, mitochondrial dysfunction and neuroinflammation, A. annua holds great promising as a potential compound to be used in the development of novel AD therapies (Figure 11). This evidence concerns the gene MAPT and Alzheimer disease.